Perspectives of Targeting mTORC1–S6K1 in Cardiovascular Aging
The global population aging is accelerating and age-associated diseases including cardiovascular diseases become more challenging. The underlying mechanisms of aging and age-associated cardiovascular dysfunction remain elusive. There are substantial evidences demonstrating a pivotal role of the mamm...
Main Authors: | Ming, Xiu-Fen, Montani, Jean-Pierre, Yang, Zhihong |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Research Foundation
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265748/ |
Similar Items
-
Glutaminolysis feeds mTORC1
by: Durán, Raúl V., et al.
Published: (2012) -
Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
by: Luo, Yan, et al.
Published: (2015) -
RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
by: Weinberg, Mark A.
Published: (2016) -
mTORC2 takes the longevity stAGE
by: Lamming, Dudley W.
Published: (2014) -
Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model
by: Salama, Mohamed, et al.
Published: (2018)